Subrata Ghosh

About

My research interests are in inflammatory bowel disease and immunopathogenesis of inflammation. My current work is focused on immune cell plasticity, especially in dendritic cells, macrophages and T cells. I am actively involved in novel targeted therapies in inflammatory bowel disease and early discovery compounds. I am also involved in clinical research on novel tools to address quality of life such as PRISM and IBD disk. I am a member of the International Organization for Study of IBD (IOIBD) and a Fellow of the Canadian Academy of Health Sciences. I am also a Fellow of the Academy of Medical Sciences, UK. I am past associate editor of Gut, past editor in chief of Canadian Journal of Gastroenterology & Hepatology, current editor in chief of World Journal of Gastroenterology, associate editor of Therapeutic Advances in Gastroenterology and Specialist editor of British Medical Bulletin.

Employment

• University College Cork Chair and Head of Dept of Medicine, Principal Investigator and deputy director APC Microbiome Ireland
  2021 - Present
• University of Birmingham Honorary Professor
  2021 - Present
• University of Birmingham Director Institute of Translational Medicine
  2016 - 2020
• University of Calgary Chairman Department of Medicine
  2011 - 2016
• Imperial College London Professor
  2002 - 2009
• University of Edinburgh Senior Lecturer
  1995 - 2002
• Bristol Royal Infirmary
  1987 - 1990

Education

• University of Edinburgh Doc

Projects & Funding

Projects & funding information is unavailable.

Publications (190)

• Histologic signatures as predictors of intestinal barrier impairment in inflammatory bowel disease: integration with endoscopic and molecular markers
  Journal of Crohn's and Colitis 2026 DOI: 10.1093/ecco-jcc/jjag076
  +Save
• Impact of Delayed Diagnosis in IBD on Clinical Outcomes and Healthcare Delivery
  Diagnostics 2026 DOI: 10.3390/diagnostics16071043
  +Save
• Empowering Patient Voices: Revolutionising Inflammatory Bowel Disease Research Through Patient and Public Involvement
  JCC Plus 2026 DOI: 10.1002/jcc5.70020
  +Save
• Generative Sonification of Synthetic Virology Data with Waveshaping and Granular Synthesis Techniques
  Leonardo 2026 DOI: 10.1162/LEON.a.2583
  +Save
• Delayed IBD Diagnosis Leads to Worse Outcomes over the Years, with Multiple Implications for Service Delivery
  2026 DOI: 10.20944/preprints202601.1516.v1
  +Save
• Practical considerations for the use of IL-23p19 inhibitors in inflammatory bowel disease: how to choose between them and why it matters?
  Journal of Crohn’s and Colitis 2025 DOI: 10.1093/ecco-jcc/jjaf144
  +Save
• Rediscovering histology – the application of artificial intelligence in inflammatory bowel disease histologic assessment
  Therapeutic Advances in Gastroenterology 2025 DOI: 10.1177/17562848251325525
  +Save
• Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine
  Gut 2025 DOI: 10.1136/gutjnl-2024-333994
  +Save
• Novel Transcriptomic Signatures In Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, And Putative Therapeutic Targets
  2025 DOI: 10.1093/ibd/izaf021
  +Save
• Artificial intelligence–enabled histology exhibits comparable accuracy to pathologists in assessing histological remission in ulcerative colitis: a systematic review, meta-analysis, and meta-regression
  Journal of Crohn's and Colitis 2025 DOI: 10.1093/ecco-jcc/jjae198
  +Save